3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
7
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Mesothelioma, Malignant
4
Urethral Neoplasms
3
Small Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Medulloblastoma
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Solitary Fibrous Tumor, Pleural
1
Sertoli-Leydig Cell Tumor
1
Interventions
Ifosfamide
10
Carboplatin
8
Paclitaxel
7
Etoposide
7
Filgrastim
5
Dexamethasone
3
Cisplatin
3
Thiotepa
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Ondansetron
2
Mesna
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Cyclophosphamide
2
Calcium Dobesilate
2
Bleomycin
2
Aprepitant
2
tremelimumab
1
thymoglobulin
1
sodium thiosulfate
1
poly ICLC
1
pembrolizumab
1
pegfilgrastim
1
palifosfamide lysine
1
palbociclib
1
isophosphamide mustard
1
fosaprepitant
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Testicular Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
No trials found.